Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

SEC Filings

Filing date Description Form Filing Group View

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
View HTML

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A
Proxy Filings
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Annual report which provides a comprehensive overview of the company for the past year

10-K
Annual Filings
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
View HTML

Copyright Morningstar